Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Prospective Investigation of Genetic Alterations in Osteolytic Lesions Compared to Paired Random Aspirates

Sandra Sauer, MD, Jens Hillengass, MD, Barbara Wagner, Daniel Spira, MD, Marc Andre Weber, MD, Stefan Hemmer, Stefan Delorme, MD, Jennifer Mosebach, MD, Martin Freitag, MD, Antonia Strauss-Dimitrakopoulou, Hartmut Goldschmidt, MD, Mindaugas Andrulis, MD, Brian Durie, MD, Dirk Hose, MD, Anja Seckinger, MD

Blood (2016) 128 (22): 4419.

https://doi.org/10.1182/blood.V128.22.4419.4419

Published: 2016

Journal Articles

Oncogene Induced Senescence As a Potential Breakpoint Mechanism Against Malignant Transformation in Plasma Cell Disorders

Nicola Lehners, MD, Elena Ellert, MD, Jing Xu, Hartmut Goldschmidt, MD, Mindaugas Andrulis, MD, Marc S. Raab, MD

Blood (2016) 128 (22): 4474.

https://doi.org/10.1182/blood.V128.22.4474.4474

Published: 2016

Journal Articles

Targeted Sequencing of Relapsed/Refractory Myeloma Patients Identifies an Enrichment of Mutations in Cereblon and MAPK Pathways

Blood (2015) 126 (23): 723.

https://doi.org/10.1182/blood.V126.23.723.723

Published: 2015

Journal Articles

BRAF Inhibition in Hairy Cell Leukemia: Multicentre Experience of 21 Patients Treated with Vemurafenib

Dietrich Sascha, MD, Andreas Pircher, MD, Mindaugas Andrulis, MD, Elena Ellert, MD, Frédéric Peyrade, Clemens-Martin Wendtner, MD, George A Follows, Martin JS Dyer, Thomas Elter, MD, Robert Zeiser, Anita Gaehler, MD, Michael Herrmann, Michael Herold, MDPhD, Claire Dearden, MD, Hanno Glimm, MD, Michael Hallek, MD, Anthony D Ho, MD, Michael Steurer, Thorsten Zenz, MD

Blood (2014) 124 (21): 3634.

https://doi.org/10.1182/blood.V124.21.3634.3634

Published: 2014

Journal Articles

Signaling Pathway Profiling in Multiple Myeloma

Marc S Raab, MD, Jing Xu, MSc, Thomas Hielscher, Nicola Lehners, MD, Elena Ellert, MD, Anthony D. Ho, MD FRCPC, Peter Schirmacher, MDPhD, Hartmut Goldschmidt, MD, Mindaugas Andrulis, MD

Blood (2014) 124 (21): 644.

https://doi.org/10.1182/blood.V124.21.644.644

Published: 2014

Journal Articles

Continued Response off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia

Sascha Dietrich, MD, Jennifer Hüllein, Michael Hundemer, Nicola Lehners, MD, Alexander Jethwa, David Capper, MD, Till Acker, MD, Boyan Garvalov, PhD, Mindaugas Andrulis, MD, Carolin Blume, Julia Meissner, MD, Stefan Fröhling, MD, Christof von Kalle, MD, Hanno Glimm, MD, Anthony D. Ho, MD, Thorsten Zenz, MD

Blood (2012) 120 (21): 4600.

https://doi.org/10.1182/blood.V120.21.4600.4600

Published: 2012

Journal Articles

The Proliferation Inhibitor CDKN1C (P57KIP2) Is Over Expressed in CD34+ Cells of Patients with MDS and Determines a Worse Prognosis Independently of IPSS Score Factors

Sascha Dietrich, MD, Mindaugas Andrulis, MD, Andrea Pellagatti, PhD, Aleksandar Radujkovic, MD, Ulrich Germing, MD, Stephan Baldus, MD, Thomas Giese, MD, Jacqueline Boultwood, MD, Peter H Krammer, PhD, Peter Dreger, MD, Anthony D. Ho, MD, Thomas Luft, MD

Blood (2012) 120 (21): 3820.

https://doi.org/10.1182/blood.V120.21.3820.3820

Published: 2012

Journal Articles

BRAF V600E Mutations in Multiple Myeloma: Clinical and Therapeutic Implications

Nicola Lehners, MD, Mindaugas Andrulis, MD, David Capper, MD, Andreas von Deimling, MD, Anthony D Ho, MD, Hartmut Goldschmidt, MD, Kai Neben, MD, Marc S Raab, MD

Blood (2012) 120 (21): 4040.

https://doi.org/10.1182/blood.V120.21.4040.4040

Published: 2012

Journal Articles

Role and Regulation of Heat Shock Proteins 90alpha and 90beta in Multiple Myeloma.

Manik Chatterjee, MD, Sarika Jain, Thorsten Stühmer, PhD, Mindaugas Andrulis, MD, Ute Ungethüm, MD, Ralf-Jurgen Kuban, PhD, Kurt Bommert, PhD, Max Topp, MD, Doris Krämer, MD, Hans K. Müller-Hermelink, MD, Herrmann Einsele, MD, Greiner Axel, MD, Ralf C. Bargou, MD

Blood (2006) 108 (11): 5029.

https://doi.org/10.1182/blood.V108.11.5029.5029

Published: 2006

NARROW

Prospective Investigation of Genetic Alterations in Osteolytic Lesions Compared to Paired Random Aspirates

Oncogene Induced Senescence As a Potential Breakpoint Mechanism Against Malignant Transformation in Plasma Cell Disorders

Targeted Sequencing of Relapsed/Refractory Myeloma Patients Identifies an Enrichment of Mutations in Cereblon and MAPK Pathways

BRAF Inhibition in Hairy Cell Leukemia: Multicentre Experience of 21 Patients Treated with Vemurafenib

Signaling Pathway Profiling in Multiple Myeloma

Continued Response off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia

The Proliferation Inhibitor CDKN1C (P57KIP2) Is Over Expressed in CD34+ Cells of Patients with MDS and Determines a Worse Prognosis Independently of IPSS Score Factors

BRAF V600E Mutations in Multiple Myeloma: Clinical and Therapeutic Implications

Role and Regulation of Heat Shock Proteins 90alpha and 90beta in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only